• Isturisa Effective in Treating Cushing’s Syndrome Other Than Cushing’s Disease, Phase 2 Trial Shows
  • Isturisa Shows Sustained Responses in Cushing’s Disease Patients in LINC-4 Trial
  • Alexion Charitable Foundation Giving $1.1M to Assist Rare Disease Community During Pandemic
  • Cushing’s Patients Need Special Monitoring in Light of COVID-19, Experts Say
  • Coalition Will Address Racial Disparities in Rare Disease Communities
  • Isturisa Now Available in France, Recordati Announces
  • Isturisa Now Available for Adult Cushing’s Patients in the U.S.
  • COVID-19 Delaying Rare Disease and Gene Therapy Trials, Pharma Execs Say
  • Eurordis Urges Expansion of Newborn Screening Initiatives Across Europe
  • Unity and EU-wide Efforts Focus of Online Rare Disease Meeting
  • Enrollment Completed for Phase 3 Trial Testing Recorlev for Endogenous Cushing’s Syndrome
  • Rare Diseases Clinical Research Network Opens Online Survey on COVID-19
Latest Posts
    The User does not have any posts